跳至主要内容
临床试验/EUCTR2012-004969-40-DK
EUCTR2012-004969-40-DK进行中(未招募)1 期

An AMH based indivdualised controlled ovarian stimulation regiment usingCorifollitrophin or graded doses of rFSH versus a standard protocol. Arandomised controlled trial

Fertility Clinic, Copenhagen University Hospital, Rigshospitalet0 个研究点开始时间: 2012年11月23日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • - Women with evidence of COS a view IVFeller ICSI
  • - First treatment with IVF / ICSI in the department
  • - Age between 25-38 years;
  • - AMH is between 5-50
  • - Weight <75kg
  • - Normal menstrual cycle length of 24 to 35 days, which are presumably
  • - Two ovaries;
  • - Uterus with expected normal function (eg. No clinically significant
  • fribromer) documented by ultrasound at screening;
  • - Willing and able to sign the informed consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 216
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -History of current PCOS or endometriosis stage III / IV
  • -History of severe ovarian hyperstimulation syndrome;
  • - Presence of hydrosalpinx by ultrasound;
  • - History of recurrent consecutive miscarriages (> 3)
  • -FSH> 12 IU / L (in the early follicular phase);
  • - Contraindications for use of gonadotropins or GnRH analogues;
  • -History of current epilepsy, HIV infection, diabetes or cardiovascular,
  • gastrointestinal, hepatic, renal, or pulmonary disease;
  • - Pregnancy, lactation or contraindication to pregnancy;
  • - Current or previous (last 12 months) abuse of alcohol or drugs;
  • - History of chemotherapy (except gestationelle reasons) and
  • radiotherapy;
  • - Undiagnosed vaginal bleeding;
  • - Tumors of the ovary, breast, adrenal, pituitary or hypothalamus and
  • malformations of sexual organs incompatible with pregnancy;
  • - Abnormal karyotype of the patient (if karyotype is performed);
  • - Hypersensitivity to study drug.

研究者

发起方
Fertility Clinic, Copenhagen University Hospital, Rigshospitalet

相似试验